Deutsche Bank’s Ligand Pharmaceuticals LGND Stock Holding History

Deutsche Bank’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-128	Closed	-$12K	–	4231
2021 Q4	$12K	Sell	128 -112	-47%	-$10.3K	﹤0.01%	4156
2021 Q3	$21K	Buy	+240	New	+$18.6K	﹤0.01%	4231
2020 Q4	–	Sell	-38	Closed	-$2K	–	4466
2020 Q3	$2K	Buy	+38	New	+$2.59K	﹤0.01%	4288
2019 Q4	–	Sell	-404	Closed	-$25K	–	5067
2019 Q3	$25K	Sell	404 -26	-6%	-$1.63K	﹤0.01%	4238
2019 Q2	$30K	Hold	430	–	–	﹤0.01%	4697
2019 Q1	$33K	Buy	+430	New	+$32.6K	﹤0.01%	4682
2018 Q3	–	Sell	-71	Closed	-$9K	–	5459
2018 Q2	$9K	Sell	71 -593	-89%	-$66.2K	﹤0.01%	5164
2018 Q1	$68K	Buy	664 +311	+88%	+$30.8K	﹤0.01%	4648
2017 Q4	$30K	Buy	+353	New	+$30.6K	﹤0.01%	4578
2013 Q4	–	Sell	-128	Closed	-$1K	–	5565
2013 Q3	$1K	Buy	+128	New	+$3.6K	﹤0.01%	5417

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Deutsche Bank's LGND Position: Q1 2026 in Review

Deutsche Bank reduced its Ligand Pharmaceuticals (LGND) stake by 0.57% in Q1 2026, selling an estimated $348K and leaving 306,111 shares worth $61.1M. The position accounts for 0.02% of the portfolio, ranked #591.

Deutsche Bank first reported a position in LGND in Q2 2013 and has held it in 52 quarters since. The position peaked at $115M in Q2 2018. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

Deutsche Bank held 306,111 shares of Ligand Pharmaceuticals worth $61.1M as of Q1 2026.
Deutsche Bank sold 1,760 Ligand Pharmaceuticals shares in Q1 2026, an estimated $348K.
Ligand Pharmaceuticals made up 0.02% of Deutsche Bank's portfolio in Q1 2026, its #591 holding.
Deutsche Bank first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
Deutsche Bank's Ligand Pharmaceuticals position peaked at $115M in Q2 2018.
357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.